Brookfield Asset Management Cancels $6.8 Billion Buyout of Spain Pharmaceutical & Healthcare Giant Grifols Over Valuation Disagreement, Deal was to Privatise Grifols in Partnership by Brookfield & Grifols, Grifols Board Had Rejected $6.8 Billion Offer, Grifols was Founded in 1909 by Josep Antonio Grífols Roig
28th November 2024 | Hong Kong
Brookfield Asset Management ($1 trillion AUM) has cancelled the $6.8 billion buyout of Spain pharmaceutical & healthcare giant Grifols over valuation disagreement, with the deal was to privatise Grifols in partnership by Brookfield & Grifols. Grifols Board had rejected the $6.8 Billion offer. Grifols was founded in 1909 by Josep Antonio Grífols Roig. Announcement (27/11/24): “The Board of Directors of Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced the termination of discussions with Brookfield Capital Partners (UK) Limited (“Brookfield”) regarding a potential acquisition of Grifols shares. This followed the statement on November 19 by the Board of Directors of Grifols, based on the recommendation of its Transaction Committee, that it would not recommend shareholders of the company to accept a potential offer from Brookfield with a valuation of €6.45 billion for the entirety of the company’s outstanding share capital (comprising both Class A and Class B shares). This indicative, non-binding valuation from Brookfield implied a price of €10.50 per Class A share, which was deemed to significantly undervalue the company’s fundamental prospects and long-term potential. This assessment is supported by the company’s robust financial performance, as highlighted in its Q3 2024 results, which demonstrate Grifols’ strong fundamentals and its ability to capture substantial global demand across key markets. Year-to-date revenues increased by 9.1% at constant currency year-over-year, driven by solid results across all business divisions and also maintains a solid financial position. In recent months, Grifols has successfully reduced its leverage, following the repayment of senior secured debt after receiving €1.6 billion from the sale of a 20% equity stake in Shanghai RAAS, along with a notable improvement in EBITDA adjusted, which for the last twelve months reached €1.7bn. This announcement comes after a comprehensive due diligence exercise has been conducted, with Brookfield granted access to all requested information. Throughout this period, Grifols provided full access to the company’s data and management, which was sufficient to make an informed assessment of the company’s fundamental value in the context of a potential public tender offer. The Board of Directors and management team of Grifols remain fully committed to executing the company’s strategic plan, which is focused on enhancing long-term value. In alignment with this commitment, Grifols will soon announce a Capital Markets Day, where it will present its strategic vision under new leadership, alongside key initiatives designed to unlock growth opportunities and drive sustained performance.”
“ Brookfield Asset Management Cancels $6.8 Billion Buyout of Spain Pharmaceutical & Healthcare Giant Grifols Over Valuation Disagreement, Deal was to Privatise Grifols in Partnership by Brookfield & Grifols, Grifols Board Had Rejected $6.8 Billion Offer, Grifols was Founded in 1909 by Josep Antonio Grífols Roig “
Brookfield Asset Management Cancels $6.8 Billion Buyout of Spain Pharmaceutical & Healthcare Giant Grifols Over Valuation Disagreement, Deal was to Privatise Grifols in Partnership by Brookfield & Grifols, Grifols Board Had Rejected $6.8 Billion Offer, Grifols was Founded in 1909 by Josep Antonio Grífols Roig
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
